Finance

Lists
4559:TYO
Zeria Pharmaceutical Co Ltd
JP¥ १,९१४.००
+०.५८%
(+११.००) 1D
अक्टोबर ६, १५:३०:०० GMT+९  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4559...
Open
JP¥ १,९०३
High
JP¥ १,९१९
Low
JP¥ १,९००
Mkt. cap
९५.९३ अरब
Avg. vol.
१.७० लाख
Volume
१.३८ लाख
Dividend
२.५६%
Quarterly dividend
JP¥ १२
Ex-dividend date
२०२६ सेप्टेम्बर २९
P/E ratio
१०.२५
52-wk high
JP¥ २,४३४
52-wk low
JP¥ १,८७८
EPS
JP¥ १८७
Shares outstanding
५.०१ करोड
No. of employees
२ हजार
Open
JP¥ १,९०३
High
JP¥ १,९१९
Low
JP¥ १,९००
Mkt. cap
९५.९३ अरब
Avg. vol.
१.७० लाख
Volume
१.३८ लाख
Dividend
२.५६%
Quarterly dividend
JP¥ १२
Ex-dividend date
२०२६ सेप्टेम्बर २९
P/E ratio
१०.२५
52-wk high
JP¥ २,४३४
52-wk low
JP¥ १,८७८
EPS
JP¥ १८७
Shares outstanding
५.०१ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
The Washington Post
The Washington Post
·
५७ मिनेट पहिले
Stocks hit new record high even as consumers feel dreary
MarketForces Africa
MarketForces Africa
·
२९ मिनेट पहिले
XRP Establishes Price Floor Ahead Of Evernorth Nasdaq Listing
Simply Wall Street
Simply Wall Street
·
३ मिनेट पहिले
Sovereign AI Deal Might Change The Case For Investing In Palantir (PLTR)
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG. In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK. In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988. In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries, It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma. The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries. The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees१.७५ हजार
Founded१९५५ डिसेम्बर २२
Headquarters-
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२०.४७ अरब
२४.१२ अरब
२५.०८ अरब
२१.४५ अरब
Cost of goods sold
५.५९ अरब
६.३८ अरब
६.४३ अरब
६.२२ अरब
Cost of revenue
५.५९ अरब
६.३८ अरब
६.४३ अरब
६.२२ अरब
Research and development expenses
-
-
३.७१ अरब
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१२.७६ अरब
१२.८२ अरब
४.८५ अरब
१३.२८ अरब
Operating expense
१२.७६ अरब
१२.८२ अरब
१४.८४ अरब
१३.२८ अरब
Total operating expenses
१८.३५ अरब
१९.१९ अरब
२१.२७ अरब
१९.५० अरब
Operating income
२.१२ अरब
४.९३ अरब
३.८१ अरब
१.९५ अरब
Other non operating income
-२.३० करोड
-८.१० करोड
३०.५० करोड
-४.७३ करोड
EBT including unusual items
९९.४० करोड
४.६३ अरब
३.९२ अरब
१.४३ अरब
EBT excluding unusual items
९९.४० करोड
४.६३ अरब
३.७६ अरब
१.४३ अरब
Income tax expense
३८.३० करोड
७९.५४ करोड
९७.९६ करोड
५४.७६ करोड
Effective tax rate
३८.५३%
-
२५.०२%
३८.२१%
Other operating expenses
-
-
-
-
Net income
६४.७० करोड
३.८२ अरब
२.९० अरब
८६.६२ करोड
Net profit margin
३.१६%
-
११.५६%
४.०४%
Earnings per share
-
-
-
-
Interest and investment income
३.०० करोड
१३.६७ करोड
३.२३ करोड
३०.५० करोड
Interest expense
-११.९० करोड
-१२.३० करोड
-१३.८० करोड
-१३.२० करोड
Net interest expenses
-८.९० करोड
१.३७ करोड
-१०.५७ करोड
१७.३० करोड
Depreciation and amortization charges
-
-
५.७८ अरब
-
EBITDA
३.८८ अरब
६.८१ अरब
५.६५ अरब
४.२४ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू